Government ContextGovernment Context
ActivityRulesGrantsPress releasesHearingsBills
ViewsAgenciesTopicsOrganizationsCommitteesLegislators
PricingLog inCreate account

Table of contents

DetailsRelated

Exhibit 12 - Berenbaum Subcutaneous Tanezumab for OA Efficacy and Safety Results Ann Rheum Dis 2020 79 800-810

FDA-2026-P-6249-0020Supporting & Related Material
Document

Details

The document's own metadata, straight from the source system.

Title
Exhibit 12 - Berenbaum Subcutaneous Tanezumab for OA Efficacy and Safety Results Ann Rheum Dis 2020 79 800-810
Posted
Jun 3, 2026
Agency
Food and Drug Administration (FDA)
Topics
View on regulations.gov ↗